Total Payments
$1,124
2024 Payments
$422.68
Companies
17
Transactions
51
Medicare Patients
221
Medicare Billing
$13,855
Payment Breakdown by Category
Food & Beverage$1,124 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,124 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $293.18 | 12 | $0 (2024) |
| Novo Nordisk Inc | $175.56 | 6 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $158.10 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $66.90 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $65.28 | 3 | $0 (2023) |
| Lilly USA, LLC | $52.79 | 3 | $0 (2023) |
| PFIZER INC. | $52.78 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $46.12 | 2 | $0 (2024) |
| Noven Therapeutics, LLC | $41.58 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $30.42 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.68 | 19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($158.10) |
| 2023 | $344.36 | 17 | ABBVIE INC. ($208.23) |
| 2022 | $357.09 | 15 | Novo Nordisk Inc ($175.56) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $29.57 | General |
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Central Nervous System | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.74 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: PSYCHIATRY | ||||||
| 07/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: PSYCHIATRY | ||||||
| 07/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Neurology | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: ADHD | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: ADHD | ||||||
| 08/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardio-renal | ||||||
| 05/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Cardiovascular | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 31 | $5,053 | $943.22 |
| 2022 | 2 | 84 | 131 | $21,857 | $6,161 |
| 2021 | 2 | 119 | 143 | $18,611 | $6,751 |
Total Patients
221
Total Services
305
Medicare Billing
$13,855
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 31 | $5,053 | $943.22 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 111 | $17,892 | $4,677 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 20 | $3,965 | $1,484 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 84 | $13,258 | $4,594 | 34.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 47 | 59 | $5,353 | $2,157 | 40.3% |
About David Julien, FNP
David Julien, FNP is a Family healthcare provider based in Oceanside, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1194149658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Julien, FNP has received a total of $1,124 in payments from pharmaceutical and medical device companies, with $422.68 received in 2024. These payments were reported across 51 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,124).
As a Medicare-enrolled provider, Julien has provided services to 221 Medicare beneficiaries, totaling 305 services with total Medicare billing of $13,855. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Oceanside, NY
- Active Since 02/04/2014
- Last Updated 02/04/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1194149658
Products in Payments
- VRAYLAR (Drug) $293.18
- CAPLYTA (Drug) $158.10
- Ozempic (Drug) $124.99
- TRELEGY ELLIPTA (Drug) $65.28
- ELIQUIS (Drug) $64.33
- REXULTI (Drug) $42.04
- Xelstrym (Drug) $41.58
- Rybelsus (Drug) $34.99
- TRULICITY (Drug) $34.55
- UZEDY (Drug) $29.66
- Qelbree (Drug) $29.33
- ABILIFY MAINTENA (Drug) $24.86
- VIVITROL (Drug) $24.15
- GARDASIL 9 (Biological) $19.73
- PREVNAR 20 (Biological) $18.87
- MOUNJARO (Drug) $18.24
- Austedo XR (Drug) $16.46
- Kerendia (Drug) $13.43
- BREZTRI (Drug) $12.82
- ImmunoCAP (Device) $12.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Oceanside
Sara Andolina, Np, NP
Family — Payments: $6,468
Family $6,468
Mrs. Frances Peredo, Fnp, FNP
Family — Payments: $3,063
Family $3,063
Tobiah Clukey, Fnp-C, FNP-C
Family — Payments: $2,835
Family $2,835
Chasidy Vitale, Fnp, FNP
Family — Payments: $1,775
Family $1,775
Jennifer Egbert, F.n.p, F.N.P
Family — Payments: $1,060
Family $1,060
Judith Brown, Np, NP
Family — Payments: $871.62
Family $871.62